10
Institutional Ethics Committee Govt. Medical College Aurangabad (MS) “IEC-GMCA” CDSCO Reg. No.ECR/314/Inst/MH/2013

Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

Embed Size (px)

Citation preview

Page 1: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

Institutional Ethics Committee Govt. Medical College

Aurangabad (MS)

“IEC-GMCA”

CDSCO Reg. No.ECR/314/Inst/MH/2013

Page 2: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

IEC- GMCA REGISTRATION DETAILS

Information as available on website of CDSCO…

Central Drugs Standard Control Organization

Directorate General of Health Services, Ministry of Health and

Family Welfare, Government of India

Sl.No. Name of Ethics Committee(EC) & Address RC No.

288 Institutional Ethics Committee- Govt. Medical College Aurangabad (IEC-GMCA), office of the member secretary & Professor Head Pharmacology, Dept. of Pharmacology, Govt. Medical College , Aurangabad 431001

ECR/314/Inst/MH/2013

Page 3: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

Address of the office of the Ethics Committee.

Institutional Ethics Committee-Govt. Medical College,

Aurangabad (IEC-GMCA)

Office:

Member Secretary, Professor Head Pharmacology

Department of Pharmacology,

Govt. Medical College, Aurangabad (MS) 431 001

Contact details:

Phone(Office) 0240 2402412-17 ..Ext 273/274

Fax 2040 2402418…

“Attention to IEC-GMCA: Department of

Pharmacology”

email [email protected]

Dr S H Talib Dr. S M Doifode Chairman IEC-GMCA Member Secretary IEC-GMCA Professor and Head Medicine Professor and Head Pharmacology Department of Medicine, Department of Pharmacology,

MGM Medical College, Aurangabad Govt. Medical College, Aurangabad

CDCSO Reg :ECR/314/Inst/MH/2013

Page 4: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

MEMBERS LIST:

Institutional Ethics Committee-Govt. Medical College, Aurangabad

1. Chairperson (Clinician)

Dr.S. H.Talib(MD Medicine)

Professor of Medicine

MGM Medical college,Aurangabad.

Contact Details :07875127786

6. Member (Clinician-Surgeon)*

Dr. A. N. Beedkar (MS Surgery)

Associate Professor Surgery

Govt.Medical College, Aurangabad.

Contact Details:09823076937

2. Member Secretary (Pharmacologist)

Dr.S M Doifode(MD Pharmacology)

Professor & Head Pharmacology

Govt.Medical College,Aurangabad.

Contact Details:09422202625

7. Member (Basic Medical Scientist)

Dr M S Baig (MD Pharmacology)

Associate Professor of Pharmacology

Govt.Medical College,Aurangabad

Contact Details: 09823078631

3. Member (Clinician-Microbiologist)*

Dr A S Damle(MD Microbiology)

Professor & Head of Microbiology

Govt.Medical College, Aurangabad

Contact Details:09822678460

8. Member (Legal Expert):

Mrs B V Paranjape(LL.B)

Assistant Professor

MP Law College, Aurangabad

Contact Details: 9890798823

4. Member (Outside Clinician)

Dr.Sudhir Kulkarni(MD Medicine)

Professor of Nephrology.

MGM Medical College, Aurangabad.

Contact Details:09422713691

9. Member (Lay person):

Shri A P Dhaneshwar(BA)

Deshpandepuram, Shahnoorwade,

Aurangabad.

Contact Details: 7588399512

5. Member (Basic Medical Scientist)

Dr.K U Zine(MD FMT)

Professor & Head of FMT

Govt.Medical College, Aurangabad.

Contact Details:09405234485

Note: * are new members... added in renewal Letter to DCGI

Page 5: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

Type of clinical research reviewed by the committee:

o Postgraduate dissertations research

o Clinical Trials

o Epidemiological studies

o Ph.D research works

o Retrospective Analysis studies

o BA, BE studies

o Short term projects

o ICMR Students Projects

Page 6: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

How to apply for permission to IEC-GMCA:

1. Collect Soft copy of Application form, Protocol

format, undertaking and other formats, List of

essential documents to be submitted, from the

department of Pharmacology, GMC, and

Aurangabad and submit accordingly.

2. Application in the given format only will be accepted.

3. No Objection from the Department Heads will be

mandatory for interdepartmental studies.

4. For Sponsored studies NOC will be required from

Dean GMC, Aurangabad.

Page 7: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

orm

INSTITUTIONAL ETHICSCOMMITTEE GOVT. MEDICALCOLLEGE AURANGABAD-431001

Phone: 2402412-17 -EXT.273/274 FaxNo.0240 2402418/19 email:[email protected]

Office: Member Secretary–Professor &Head Department of Pharmacology, GMC, Aurangabad.

APPLICATIONFORM

Tittle of the study:

1.

Name of the Principal Investigator /

Post graduate student ( in block letters

with space in-between)

Mobile No

Telephone Number

Contact details of Department

email address

2.

Details of Sponsors & Contact

Address (if not write NA)

Mobile No

Telephone Number

Email address

3.

Co- Investigator (s) /PG Guide.

Mobile No (PG Guide)

Telephone Number (PG Guide)

Contact details of Department

Email address (PG Guide)

CDCSO Reg :ECR/314/Inst/MH/2013

Application Form

Office use only

1. Received Application on ___________________

2. All the documents attached or not…..Yes/No

3. IEC Fees Amount (Rs/-) :__________________

Page 8: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

4.

Name & Signature of Principal

investigator /PG student.

Name & Signature of Postgraduate

guide.

Name &Signature (s) of co-

investigators with name

Name & Signature of Head of the

department of PI/PG student

Name (s) & Signature (s) of other

Head of the department (s) in

collaborative studies.

Place where research will

be carried out…

Ex:

1. GMC, Aurangabad

2. Outside GMCA

…specify with

permission letter

Details of Financial

aspects/who is responsible

for expenses of the

study..if required attach

details as separate

ANNEXURE..

DECLARATION:

I declare that I shall follow National and International guidelines of Good Clinical Practice (GCP) in

conducting the above clinical research project. I fully owe responsibility of patient care. I am also made

aware by the fact that no changes will be done in the protocol once approved by IEC.

Signature of Principal Investigator

PrincipalInvestigatorshouldbepreparedtogivebrieforalpresentationduring IEC review meeting

Application Form

Page 9: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

Tittle of the study:

___________________________________________________________________________

___________________________________________________________________________

The study protocol submissions should include all documents as per SOP:- The following documents were submitted by me: (Tick out the submitted one)

1) Clear and explanatory research tittle, details of background of the research, study

objectives, study design, section criteria’s, study population, sample size,

interventional product details in all perspective, informed consent in vernacular

languages as applicable, procedures that will be followed, investigations, procedures

of data recording, any tech information, Data and safety monitoring procedures as

applicable.

2) For all sponsored studies conducted at Govt. Medical College, Aurangabad, Govt.

Cancer Hospital Aurangabad & Paithan Rural Hospital… It will be mandatory for

Principal Investigator to submit the NO OBJECTION certificate from the Head of

the department & Dean Govt. Medical College, Aurangabad. Without NOC

proposals will not be accepted.

3) All Details of Funding agency / Sponsors….. and fund allocation / utilization/patient

remuneration,/ Signed Indemnity Agreement./Investigator's agreement with the

Sponsors, Proposed compensation and reimbursement of incidental expenses.

Undertaking in this regard of PI & Sponsors will be compulsory.

4) CTRI Registration as Applicable.

5) Permission letters from licensing authorities (DCGI & others)

6) Precise description of methodology of the proposed research, including intended

dosages of drugs, planned duration of treatment and details of invasive procedures

if any.

7) A description of plans to withdraw or withhold standard therapies in the course of

research.

8) Procedure for seeking and obtaining informed consent with sample of patient

information sheet and informed consent forms in English and vernacular

languages.( as specified in the Appendix V of Drugs and cosmetics act 1945).

9) The detail plans for statistical analysis of the study

10) Statement of privacy & confidentiality of personal data

11) Investigators brochure

12) Undertaking by the investigator…. Appendix VII of schedule Y

13) Recent curriculum vitae of the Investigators indicating qualification and

experience

14) Safety of proposed intervention and any drug or vaccine to be tested, including

results of relevant laboratory and animal research.

Application Form

Page 10: Institutional Ethics Committee Govt. Medical College Committee.pdf · Central Drugs Standard Control Organization Directorate General of Health Services, Ministry of Health and Family

15) For research carrying more than minimal risk, an account of plans to provide

medical therapy for such risk or injury or toxicity due to over dosage should

be included.

16) SAE reporting format as applicable for all interventional studies… as specified in the

Appendix XI of Drugs and cosmetics act 1945/Pharmacovigilance guidelines.

17) All Details of Funding agency/Sponsors and fund allocation/utilization/patient

remuneration/signed indemnity/investigators agreement with sponsors, etc. for the

proposed work. Proposed compensation and reimbursement of incidental expenses.

Undertaking in this regard of PI & Sponsors will be compulsory.

18) Storage and maintenance of all data collected during the trial.

19) Plans for publication of results – positive or negative – while maintaining the

privacy and confidentiality of the study participants.

20) A statement on probable ethics issues and steps taken to tackle the same

21) All o ther r e levant documents related to the study protocol including

regulatory clearances.

22) Agreement to comply with national and international GCP protocols f o r clinical

trials.

23) Detail case record form covering all details of observation to be recorded.

24) A statement stating that NO other data/investigations/interventions will be done or

recorded in the study participants other than approved by the IEC.

25) For international collaborative study details about foreign collaborators and

documents for review of Health Ministry's Screening Committee(HMSC) or

appropriate Committees under other agencies/authority like Drug Controller General

of India (DCGI)

26) For exchange of biological material in international collaborative study a MoU/

Material Transfer Agreement between the collaborating partners.

27) A statement on conflict-of-interest (COI), if any

28) Any other relevant information is to be documented.

29) Mandatory that all Protocols submitted should have attached photo copies of the

references quoted in the study. Without references the protocol will not be

considered for review procedure…

Name & Signature of Principal Investigator

Date:

All submitted Documents will be checked before accepting the Protocol by the

Nominated member of IEC….. Incomplete Submissions will not be accepted.